Medpage Today on MSN

How to Treat Multiple Myeloma Patients With Renal Impairment

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...
MedPage Today on MSN

Achieving Cure in Multiple Myeloma

Since the beginning of this century, advances in understanding the biology of multiple myeloma have transformed the disease ...
The Manila Times

Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025

NEXICART-2 (NCT06097832) is an ongoing multi-site U.S. Phase 1/2 clinical trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory AL Amyloidosis, with a registrational design. Interim ...

Immix Biopharma, Inc.: Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025

Oral presentation Sunday, December 7, at ASH 2025 - LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), the global leader in relapsed/ ...

Next-Generation Multiple Myeloma Therapies Market to Reach USD 37.07 Billion by 2033, Driven by Accelerated Immunotherapy Approvals and Precision Medicine Adv…

According to the latest analysis by DataM Intelligence, the Next-Generation Multiple Myeloma Therapies Market Size was valued ...
Health.com

What Causes Bumps on Your Tongue?

More than 50% of people experience transient lingual papillitis, a benign form of tongue bumps. Stress and anxiety can cause tongue bumps by affecting your immune system. Bumps on the tongue could be ...